Celcuity Inc. Common Stock (CELC) Stock
Key stats
- Market cap
- $3.15B
- Price / Earnings ratio
- -12.9x
- EPS (TTM)
- -$4.72
- Volume
- Loading
- 52-week high
- $151.02
- 52-week low
- $53.54
Source: third-party data provider, as of November 13, 2026
Compare with CELC
Recent news

New Strong Sell Stocks for October 14th
New Strong Sell Stocks for October 14th
CELC

Why Celcuity Stock Was a Winner on Wednesday
Why Celcuity Stock Was a Winner on Wednesday
CELC

Celcuity Q2 Earnings Call Highlights
Celcuity Q2 Earnings Call Highlights
CELC

CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CELC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 43.02
- MACD 12/26/9
- -1.35
- EMA 9 of MACD
- -1.95
- MACD histogram
- 0.60
- SMA 50
- $73.75
- Price below SMA 50
- EMA 50
- $73.05
- Price below EMA 50
- SMA 200
- $98.94
- Price below SMA 200
- EMA 200
- $92.77
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 9 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

New Strong Sell Stocks for October 14th
New Strong Sell Stocks for October 14th
CELC

Why Celcuity Stock Was a Winner on Wednesday
Why Celcuity Stock Was a Winner on Wednesday
CELC

Celcuity Q2 Earnings Call Highlights
Celcuity Q2 Earnings Call Highlights
CELC

CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CELC

CELC Investors Have Opportunity to Join Celcuity Inc. Fraud Investigation with SBS Law
CELC Investors Have Opportunity to Join Celcuity Inc. Fraud Investigation with SBS Law
CELC

NASDAQ: CELC Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm
NASDAQ: CELC Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm
CELC

Why CELC Stock Declined 15% in a Week Despite a Major FDA Win
Why CELC Stock Declined 15% in a Week Despite a Major FDA Win
CELC

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
CELC

Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval
Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval
CELC

Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer
Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer
CELC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Celcuity Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Brian F. Sullivan | Co-Founder, Chairman & CEO | 1962 |
| Ms. Vicky Hahne CPA | Chief Financial Officer | 1966 |
| Dr. Lance G. Laing Ph.D. | Co-Founder, Chief Science Officer, VP, Secretary & Director | 1962 |
| Ms. Jodi Sievers | Head of Investor Relations & Corporate Communications | — |
| Ms. Sheri Smith | Acting Head of Clinical Operations | — |
| Mr. Igor Gorbatchevsky M.D. | Chief Medical Officer | — |
| Mr. Eldon C. Mayer III, M.B.A. | Chief Commercial Officer | 1961 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 43.02
- MACD 12/26/9
- -1.35
- EMA 9 of MACD
- -1.95
- MACD histogram
- 0.60
- SMA 50
- $73.75
- Price below SMA 50
- EMA 50
- $73.05
- Price below EMA 50
- SMA 200
- $98.94
- Price below SMA 200
- EMA 200
- $92.77
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
9 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $134.00
- Average
- $155.22
- High
- $177.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -14.2 | -8.4 | ||||||||||
| 2022 | -16.6 | -11.3 | -8.4 | -28.8 | +2.0 | +43.8 | -0.1 | +7.6 | +0.4 | -0.9 | -9.1 | +71.7 |
| 2023 | -25.3 | +22.5 | -10.1 | +2.3 | +11.4 | -2.9 | -2.5 | -4.4 | -7.2 | +16.6 | +45.5 | -2.1 |
| 2024 | +2.2 | +2.2 | +23.9 | -24.1 | -3.1 | +9.4 | +10.2 | -11.0 | -4.5 | +6.3 | -14.3 | +3.6 |
| 2025 | -9.0 | -25.7 | +13.6 | +19.9 | -1.6 | +14.9 | +213.6 | +28.4 | -7.8 | +70.6 | +34.5 | +1.3 |
| 2026 | +8.8 | +0.3 | +5.4 | +7.5 | +5.8 | -14.9 | -17.3 | +1.5 | -13.5 | -8.0 | -4.1 |



